Introduction: Screening of pregnant women for hypothyroidism during the pregnancy to detect hypothyroidism and prevent congenital hypothyroidism during pregnancy.
Screening is defined as the application of a test to detect a potential disease or condition in a person who has no known signs or symptoms of that condition at the time the test is done. The presence of the condition, however, should have proven adverse effects which can be prevented by early detection and treatment.
Materials and Methods: This is a observational study for a period of one year from October 2017 to October 2018 wherein a number of pregnant women were screened for hypothyroidism during Pregnancy by using TSH levels as a criteria.
1.Most of the women (61.5%), had made their first visit to the tertiary hospital after their 24 weeks of gestation and 19.8% of them had their TSH level between 5 and 9.99 mIU/dL.
2.Majority of women (87%) had term deliveries irrespective of their hypothyroid level.
3.About 54% of deliveries were LSCS and one was spontaneous expulsion.
Conclusion: The study clearly showed that maternal outcome operative surgery (LSCS) was statistically significant. All the three TSH sub groups LSCS was done as upto4.99 group as 32.3%, 5 to 9.99 group as 18.7% and 10 and above group as 3.1%
Like GDM screening, Gestational Thyroid Dysfunction (GTD) screening among Antenatal Women in the First trimester registration should be made compulsory in all Hospitals by Government. This will lead to early and effective treatment of thyroid disorders that ensures safe pregnancy with minimal maternal and fetal complications and also lesser operative surgery, which leads to lot of complications to women.